Regionally distinct trophoblast regulate barrier function and invasion in the human placenta

  1. Bryan Marsh
  2. Yan Zhou
  3. Mirhan Kapidzic
  4. Susan Fisher  Is a corresponding author
  5. Robert Blelloch  Is a corresponding author
  1. University of California, San Francisco, United States

Abstract

The human placenta contains two specialized regions: the villous chorion where gases and nutrients are exchanged between maternal and fetal blood, and the smooth chorion which surrounds more than 70% of the developing fetus but whose cellular composition and function is poorly understood. Here, we use single cell RNA sequencing to compare the cell types and molecular programs between these two regions in the second trimester human placenta. Each region consists of progenitor cytotrophoblasts (CTBs) and extravillous trophoblasts (EVTs) with similar gene expression programs. While CTBs in the villous chorion differentiate into syncytiotrophoblasts, they take an alternative trajectory in the smooth chorion producing a previously unknown CTB population which we term smooth-chorion-specific CTBs (SC-CTBs). Marked by expression of region-specific cytokeratins, the SC-CTBs form a stratified epithelium above a basal layer of progenitor CTBs. They express epidermal and metabolic transcriptional programs consistent with a primary role in defense against physical stress and pathogens. Additionally, we show that SC-CTBs closely associate with EVTs and secrete factors that inhibit the migration of the EVTs. This restriction of EVT migration is in striking contrast to the villous region where EVTs migrate away from the chorion and invade deeply into the decidua. Together, these findings greatly expand our understanding of CTB differentiation in these distinct regions of the human placenta. This knowledge has broad implications for studies of the development, functions, and diseases of the human placenta.

Data availability

Sequencing data have been deposited in GEO under the accession code GSE198373Processed data have been deposited on Figshare at https://figshare.com/projects/Regionally_distinct_trophoblast_regulate_barrier_function_and_invasion_in_the_human_placenta/135191.Code to generate the processed data have been deposited on GitHub at https://github.com/marshbp/Regionally-distinct-trophoblast-regulate-barrier-function-and-invasion-in-the-human-placenta.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Bryan Marsh

    Department of Urology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4979-5233
  2. Yan Zhou

    Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Mirhan Kapidzic

    The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Susan Fisher

    The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell, University of California, San Francisco, San Francisco, United States
    For correspondence
    susan.fisher@ucsf.edu
    Competing interests
    Susan Fisher, is a consultant for Novo Nordisk. All other authors declare no competing interests..
  5. Robert Blelloch

    Department of Urology, University of California, San Francisco, San Francisco, United States
    For correspondence
    robert.blelloch@ucsf.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1975-0798

Funding

National Institutes of Health (P50 HD055764)

  • Bryan Marsh
  • Robert Blelloch

National Institutes of Health (R37 HD076253)

  • Yan Zhou
  • Mirhan Kapidzic
  • Susan Fisher

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The University of California, San Francisco (UCSF) Institutional Review Board approved this study (11-05530). All donors gave informed consent.

Copyright

© 2022, Marsh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,979
    views
  • 599
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bryan Marsh
  2. Yan Zhou
  3. Mirhan Kapidzic
  4. Susan Fisher
  5. Robert Blelloch
(2022)
Regionally distinct trophoblast regulate barrier function and invasion in the human placenta
eLife 11:e78829.
https://doi.org/10.7554/eLife.78829

Share this article

https://doi.org/10.7554/eLife.78829

Further reading

    1. Cell Biology
    2. Developmental Biology
    Qian Wang, Hongge Li ... Xin Zhang
    Research Article

    Fibroblast growth factor (FGF) signaling elicits multiple downstream pathways, most notably the Ras/MAPK cascade facilitated by the adaptor protein Grb2. However, the mechanism by which Grb2 is recruited to the FGF signaling complex remains unresolved. Here, we showed that genetic ablation of FGF signaling prevented murine lens induction by disrupting transcriptional regulation and actin cytoskeletal arrangements, which could be reproduced by deleting the juxtamembrane region of the FGF receptor and rescued by Kras activation. Conversely, mutations affecting the Frs2-binding site on the FGF receptor or the deletion of Frs2 and Shp2 primarily impact later stages of lens vesicle development involving lens fiber cell differentiation. Our study further revealed that the loss of Grb2 abolished MAPK signaling, resulting in a profound arrest of lens development. However, removing Grb2’s putative Shp2 dephosphorylation site (Y209) neither produced a detectable phenotype nor impaired MAPK signaling during lens development. Furthermore, the catalytically inactive Shp2 mutation (C459S) only modestly impaired FGF signaling, whereas replacing Shp2’s C-terminal phosphorylation sites (Y542/Y580) previously implicated in Grb2 binding only caused placental defects, perinatal lethality, and reduced lacrimal gland branching without impacting lens development, suggesting that Shp2 only partially mediates Grb2 recruitment. In contrast, we observed that FGF signaling is required for the phosphorylation of the Grb2-binding sites on Shc1 and the deletion of Shc1 exacerbates the lens vesicle defect caused by Frs2 and Shp2 deletion. These findings establish Shc1 as a critical collaborator with Frs2 and Shp2 in targeting Grb2 during FGF signaling.

    1. Cell Biology
    2. Developmental Biology
    Jeet H Patel, Mary C Mullins
    Insight

    Disease-causing mutations in the signaling protein BMP4 impair its secretion, but only when it is made as a homodimer.